Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: Clinicopathologic study of resected tumours

Journal of Viral Hepatitis

Volumn 20, Issue 5, 2013, Pages 306-310

  Wu, Z F ^a   Yang, N ^a   Li, D Y ^a   Zhang, Hai Bin ^a   Yang, G S ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

hepatitis B virus; intrahepatic cholangiocarcinoma; surgical resection; survival

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER PATIENT; CANCER SURGERY; CLINICAL FEATURE; DATA BASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; CHOLANGIOCARCINOMA; FEMALE; HEPATITIS B; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84876154058     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12005     Document Type: Article

References (30)

1. Shaib Y, El-Serag HB,. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24: 115-125. (Pubitemid 38738341)
2. Bergquist A, Ekbom A, Olsson R, et al,. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002; 36: 321-327. (Pubitemid 34194790)
3. Watanapa P, Watanapa WB,. Liver fluke-associated cholangiocarcinoma. Br J Surg 2002; 89: 962-970. (Pubitemid 34994687)
4. Ben-Menachem T,. Risk factors for cholangiocarcinoma. Eur J Gastroenterol Hepatol 2007; 19: 615-617. (Pubitemid 47067057)
5. Kobayashi M, Ikeda K, Saitoh S, et al,. Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000; 88: 2471-2477. (Pubitemid 30331952)
6. Lee TY, Lee SS, Jung SW, et al,. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol 2008; 103: 1716-1720.
7. Hai S, Kubo S, Yamamoto S, et al,. Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma. Dig Surg 2005; 22: 432-439.
8. Lee CH, Chang CJ, Lin YJ, Yeh CN, Chen MF, Hsieh SY,. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer 2009; 100: 1765-1770.
9. Zhou H, Wang H, Zhou D, et al,. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis. Eur J Cancer 2010; 46: 1056-1061.
10. Vitale F, Tramuto F, Orlando A, et al,. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection? J Med Virol 2008; 80: 577-582. (Pubitemid 351358552)
11. Shiota G, Oyama K, Udagawa A, et al,. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53. J Med Virol 2000; 62: 151-158.
12. Patel T,. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33: 1353-1357. (Pubitemid 32496970)
13. Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH,. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 2001; 193: 384-391. (Pubitemid 32895979)
14. Nathan H, Pawlik TM,. Staging of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 2010; 26: 269-273.
15. Spear BT,. Alpha-fetoprotein gene regulation: lessons from transgenic mice. Semin Cancer Biol 1999; 9: 109-116. (Pubitemid 29265526)
16. Ishii T, Yasuchika K, Fujii H, et al,. In vitro differentiation and maturation of mouse embryonic stem cells into hepatocytes. Exp Cell Res 2005; 309: 68-77. (Pubitemid 41191224)
17. Ishii T, Fukumitsu K, Yasuchika K, et al,. Effects of extracellular matrixes and growth factors on the hepatic differentiation of human embryonic stem cells. Am J Physiol Gastrointest Liver Physiol 2008; 295: G313-G321.
18. Primary Liver Cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann Surg 1990; 211: 277-287.
19. Ishikawa K, Sasaki A, Haraguchi N, Yoshikawa Y, Mori M,. A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin. Oncologist 2007; 12: 320-324. (Pubitemid 46556798)
20. Ishii T, Yasuchika K, Suemori H, Nakatsuji N, Ikai I, Uemoto S,. Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma. Cancer Lett 2010; 294: 25-34.
21. Yamanaka N, Okamoto E, Ando T, et al,. Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma. Cancer 1995; 76: 2449-2456.
22. Shirabe K, Shimada M, Harimoto N, et al,. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery 2002; 131: S159-S164. (Pubitemid 34118633)
23. Zhou XD, Tang ZY, Fan J, et al,. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 2009; 135: 1073-1080.
24. Yamasaki S,. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 2003; 10: 288-291. (Pubitemid 37407518)
25. Jang KT, Hong SM, Lee KT, et al,. Intraductal papillary neoplasm of the bile duct associated with Clonorchis sinensis infection. Virchows Arch 2008; 453: 589-598.
26. Chen TC, Nakanuma Y, Zen Y, et al,. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology 2001; 34: 651-658. (Pubitemid 32927987)
27. Zhang F, Chen XP, Zhang W, et al,. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology 2008; 52: 224-232.
28. Zhou HB, Wang H, Li YQ, et al,. Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection. World J Gastroenterol 2011; 17: 1292-1303.
29. Zhang L, Cai JQ, Zhao JJ, et al,. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 2010; 101: 233-238.
30. Torbenson M, Thomas DL,. Occult hepatitis B. Lancet Infect Dis 2002; 2: 479-486. (Pubitemid 34826853)